This content is restricted.
Brief
On 04/08/2025, the Therapeutic Goods Administration (TGA) issued an update regarding Efficacy of Vitamin D for bone strength. The TGA initiated targeted compliance reviews of listed medicines containing Vitamin D and found insufficient evidence to support bone strength claims made by sponsors, leading to removal of claims, cancellation of four medicines, and issuance of one infringement notice.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested